BioNexus Gene Lab (BGLC) 10-Q2024 Q3 Quarterly report

Filed: 15 Nov 24, 5:00pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: acknowledged, Additionally, addressing, Advocate, aim, alternative, appeal, arm, arrangement, assigned, assist, Australia, authorised, award, Azura, Bachelor, Bar, Batu, BGS, bringing, building, buyer, called, capacity, career, CCRE, Centurion, chain, Chremrex, client, Composite, conducting, conveyancing, corrective, Court, decision, delisted, delisting, discontinued, dissolved, economy, enhance, enhanced, enhancing, entry, estate, event, excessively, expansion, experience, expertise, explained, fewer, fiduciary, Foong, formal, forward, global, grace, gradually, Hai, hearing, High, Honkuk, implemented, implementing, inappropriately, inconsistent, investigation, isolated, joint, Jook, JP, Kembangan, Kim, lack, led, legitimacy, length, Lim, line, Low, machinery, Malaya, mandated, Master, meet, meeting, mentioned, modification, Mokhtar, nil, Nomination, offset, outlined, oversight, package, paid, Panel, parent, partner, person, power, President, prompted, properly, Queensland, real, reassessment, reconciliation, reconsidered, reinforce, reinforcing, rental, repeated, request, rescinded, rescission, restricted, Seri, set, Solicitor, standard, stemmed, suspension, Taman, technical, thereto, transparency, unable, undergoing, understanding, undertaken, underway, violation, virtue, wealth, Wong

Removed: administered, aggressive, Alpha, Beta, Delta, disease, earning, employee, evolution, fear, fee, hire, key, molecular, Omicron, onset, pandemic, people, post, prominent, reluctant, schedule, table, transmissible, transmission, variant, view, visit

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

BGLC similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officers of the registrant certify, to the best of their knowledge, that the registrant’s Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the “Form 10-Q”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Form 10-Q, fairly presents, in all material respects, the financial condition and results of operations of the registrant.

Bionexus Gene Lab Corporation

Dated: November 15, 2024

/s/ Su-Leng Tan Lee
Su-Leng Tan Lee
Chief Executive Officer
(Principal Executive Officer)